起底“医美四大家族”：人性、泡沫与时代

Core Viewpoint - The article discusses the rise and influence of the "Putian system" in the medical aesthetics industry, highlighting the complex relationships and business strategies employed by four prominent families within this sector [1][2][3]. Group 1: Overview of the Putian System in Medical Aesthetics - The Putian system has significant involvement in various branches of private healthcare, particularly in the lucrative medical aesthetics sector [1]. - The push for popularizing conventional aesthetic procedures like breast augmentation, liposuction, and facial surgeries was initially driven by the "Putian system" [2]. - Four major families dominate the Putian medical aesthetics landscape: the Chen Jinxi family of Meilai, the Chen Guoxing and Chen Guoxiong brothers of Yixing, the Zhan Zongyang family of Weilin, and the Huang Defeng family, formerly of Meilian [3][4]. Group 2: Historical Context and Development - The origins of these families can be traced back to Chen Deliang, the "founding father" of the Putian medical system, who established a significant medical faction through low-cost treatments [5][6]. - The early expansion model involved setting up clinics near transportation hubs and using street advertising to attract patients, leading to a "point-based expansion + advertising" strategy [7]. - The Putian system officially entered the medical aesthetics industry in the first decade of the 21st century, motivated by the potential for high profits [8]. Group 3: Business Strategies and Operations - The Putian system merchants adapted and expanded their medical model, focusing on aggressive marketing, self-branded products, and deep ties with industry associations [9]. - The four families have seen significant growth, although many have begun to withdraw from the increasingly regulated medical aesthetics market [10]. Group 4: Case Studies of Major Families - Meilai (Chen Jinxi Family): Meilai has grown to encompass 108 member enterprises and employs over 12,600 people, offering a wide range of aesthetic services [17]. The family has faced controversies regarding its advertising practices and has been involved in numerous administrative penalties [25][24]. - Yixing (Chen Guoxing Family): This family has established a significant presence in the medical aesthetics sector, with Yixing being ranked second among private medical aesthetics chains in China as of 2017 [45]. However, they faced challenges in their IPO attempts due to concerns over compliance and sustainability [48][49]. - Weilin (Zhan Zongyang Family): Weilin has positioned itself as an international brand and has been involved in the medical aesthetics installment loan market, which has raised regulatory concerns [75][86]. - Meilian (Huang Defeng Family): This family has divested from Meilian and has seen a decline in its operations, with the company facing multiple medical disputes and administrative challenges [93][102]. Group 5: Industry Trends and Future Outlook - The medical aesthetics market is entering a phase of slower growth and increased regulation, which may limit the previously unchecked expansion of the Putian system [106]. - The article suggests that the era of the "four families" is coming to an end as they face increasing scrutiny and operational challenges, marking a significant shift in the industry landscape [107][108].